Purdue Pharma and the Sackler family have reached a $7.4 billion settlement to resolve lawsuits linked to the opioid epidemic. This settlement, significantly larger than a previous proposal, includes $6.5 billion from the Sacklers and $900 million from Purdue. Aimed at compensating victims and funding opioid crisis abatement efforts, this agreement awaits court approval. Commentary from recovery advocates highlights the devastating personal effects of opioid addiction stemming from Purdue's actions, reinforcing the need for accountability and support in recovery initiatives.
Members of the Sackler family and Purdue Pharma have reached a $7.4 billion settlement over the opioid crisis, significantly increasing compensation for victims.
The settlement involves Purdue Pharma paying $900 million and the Sackler family contributing $6.5 billion to address the opioid epidemic.
This new agreement aims to deliver billions in compensation and resources for treatment and prevention of opioid overdose, affecting numerous lives.
Kara Trainor, a recovery advocate, emphasizes how the company’s profit-driven motives altered her life, illustrating the human impact of the crisis.
Collection
[
|
...
]